Biopharma Business

Tag "Abbott"

Abbott announces CE Mark and first use of the world’s first smartphone compatible insertable cardiac monitor

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world’s first smartphone compatible ICM that will help physicians identify

Read Full Article

FDA approves Abbott’s molecular Zika virus test

The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements